US Patent Issued to Janssen Biotech on May 26 for "Methods of treatment and maintenance therapy for bladder cancer using gemcitabine" (Missouri, Massachusetts Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,300, issued on May 26, was assigned to Janssen Biotech Inc. (Horsham, Pa.).

"Methods of treatment and maintenance therapy for bladder cancer using gemcitabine" was invented by Dennis Giesing (Lee's Summit, Mo.) and Christopher Cutie (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods of treating urothelial carcinomas of the lower tract comprising administering comprising administering gemcitabine continuously and locally to the bladder of an individual in an induction therapy and/or maintenance therapy."

The patent was filed on March 9, 2023, under Application No. 18/181,467.

*For further information, including ima...